Bliss GVS Pharma advanced 2.87% to Rs 199.05 at 10:23 IST on BSE, with the stock hitting 52-week high in intraday after the company reported strong Q2 September 2017 results.
The result was announced after market hours yesterday, 30 November 2017.Meanwhile, the S&P BSE Sensex was up 77.65 points or 0.23% at 33,227.
On the BSE, 1.56 lakh shares were traded on the counter so far as against the average daily volumes of 94,000 shares in the past two weeks. The stock had hit a high of Rs 209.80 so far during the day, which is a 52-week high for the counter. The stock hit a low of Rs 196.05 so far during the day. The stock had hit a 52-week low of Rs 129 on 7 June 2017.
Bliss GVS Pharma's consolidated net profit surged 88.22% to Rs 39.49 crore on 40.24% growth in income from operations to Rs 224.43 crore in Q2 September 2017 over Q2 September 2016.
Bliss GVS Pharma is engaged in developing, manufacturing and marketing pharmaceutical formulations.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content